Hubungan Umur dan Status Komorbid dengan tingkat kematian pasien covid-19 di RSUD dr. Chasbullah Abdul Madjid Kota Bekasi
Keywords:
Covid-19, komorbcoviid, kematian, rumah sakitAbstract
Corona virus disease 2019 (COVID-19) adalah penyakit infeksi disebabkan oleh SARS-CoV-2 yang menyebabkan peningkatan morbiditas dan mortalitas yang tinggi. Tujuan penelitian ini untuk mengidentifikasi faktor-faktor yang berhubungan dengan tingkat kematian pada pasien covid-19. Metode penelitian menggunakan pendekatan observasional kohort retrospektif dengan data sekunder dari medical record. Populasi penelitian ini adalah seluruh pasien yang dirawat di RSUD dr. Chasbullah Abdul Madjid Kota Bekasi dari Bulan September 2020 sampai dengan April 2021. Sampel penelitian adalah seluruh pasien covid 19 yang berusia lebih dari 18 tahun dan memiliki komorbid sebanyak 1.371 pasien. Analisis menggunakan chi square test. Hasil penelitian ini memperlihatkan bahwa kasus pada pasien laki-laki lebih banyak 724 (52,8%) dibandingkan dengan pasien perempuan 647 (47,2%) dengan tingkat kematian pada laki-laki lebih tinggi yaitu 33,1%. Jenis komorbid yang paling banyak adalah DM, Hipertensi, Penyakit Jantung, penyakit paru dimana kejadian hipertensi, penyakit jantung dan paru prevalensi terbanyak pada laki-laki. Hasil Penelitian menunjukkan bahwa terdapat hubungan yang signifikan umur dan status komorbid dengan tingkat kematian pasien covid-19 dengan nilai p value keduanya 0.0001 dan OR pada status komorbid 5,08. Kesimpulan terdapat hubungan status komorbid yaitu komorbid lebih dari satu berisiko mengalami kematian sebesar 5 kali dibandingkan pasien yang hanya memiliki satu macam komorbid. Saran peningkatan upaya pencegahan dan penanganan faktor komorbid yang dapat memperberat dan meningkatkan risiko kematian pada pasien covid-19 dengan edukasi dan pemberian terapi
References
Burhan E, Isbaniah F, Susanto AD, Aditama TY, Soedarsono, Sartono TR et al. Pneumonia Covid-19 Diagnosisi dan penatalaksanaan di Indonesia. Vol. 55, Journal of the American Pharmacists Association. Jakarta: Hak cipta dilindungi Undang-Undang Dilarang memperbanyak, mencetak dan menerbitkan sebagian atau seluruh isi buku ini dengan cara dan dalam bentuk apapun tanpa seijin penulis dan penerbit. Diterbitkan pertama kali oleh: Perhimpunan Dokter Paru Indonesia J; 2020. 1–58 p.
Yuliana. WELLNESS AND HEALTHY MAGAZINE Corona virus diseases (Covid. Wellness And Healthy Magazine. 2020 Mar 6;2(1):187.
Chan JFW, Kok KH, Zhu Z, Chu H, To KKW, Yuan S, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerging Microbes and Infections. 2020 Jan 1;9(1):221–36.
Murillo-Zamora E, HERNANDEZ-SUAREZ C. Survival in adult inpatients with COVID-19. medRxiv. 2020 May 26;2020.05.25.20110684.
Beranda | Satgas Penanganan COVID-19 [Internet]. [cited 2020 Oct 27]. Available from: https://covid19.go.id/
Kemenkes RI. Pedoman Pencegahan dan Pengendalian Coronavirus Disease (COVID-19). Germas. 2020;0–115.
Yang Q, Zhou Y, Wang X, Gao S, Xiao Y, Zhang W, et al. Effect of hypertension on outcomes of adult inpatients with COVID-19 in Wuhan, China: A propensity score-matching analysis. Respiratory Research. 2020 Jul 6;21(1):172.
Muniyappa R, Section CE, Branch O, Diseases K, Mellitus D. Perspective : COVID-19 Pandemic , Corona Viruses , and Diabetes Mellitus Ranganath Muniyappa and Sriram Gubbi Clinical Endocrine Section , Diabetes , Endocrinology , and Obesity Branch , National Institute of Diabetes and Digestive and Kidney Diseases , N. American Journal of Physiology-Endocrinology and Metabolism. 2020;318.
The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. | 中华医学杂志; - (02):145-151, 2020. | CNKI_Lanzhou [Internet]. [cited 2020 Oct 27]. Available from: https://pesquisa.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resource/en/czh-933
Grasselli G, Greco M, Zanella A, Albano G, Antonelli M, Bellani G, et al. Risk Factors Associated with Mortality among Patients with COVID-19 in Intensive Care Units in Lombardy, Italy. JAMA Internal Medicine. 2020;180(10):1345–55.
Sistem Informasi Managemen Rumah Sakit. Laporan Bulanan. 2020.
Muhani N, Sari N. Kesintasan Penyakit Ginjal Kronik yang Menjalani Hemodialisis di Rumah Sakit Abdul Moeloek Lampung Tahun 2017-2018. Media Penelitian dan Pengembangan Kesehatan. 2020;30(3):257–64.
Zheng LW, Chen Y, Chen F, Zhang P, Wu LF. Effect of acupressure on sleep quality of middle-aged and elderly patients with hypertension. International Journal of Nursing Sciences. 2014;1(4):334–8.
Di Castelnuovo A, Bonaccio M, Costanzo S, Gialluisi A, Antinori A, Berselli N, et al. Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study. Nutrition, Metabolism and Cardiovascular Diseases. 2020;30(11):1899–913.
Zoppini G, Fedeli U, Schievano E, Dauriz M, Targher G, Bonora E, et al. Mortality from infectious diseases in diabetes. Nutrition, Metabolism and Cardiovascular Diseases. 2018 May 1;28(5):444–50.
Roncon L, Zuin M, Rigatelli G, Zuliani G. Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome. Journal of Clinical Virology. 2020 Jun 1;127:104354.
Woolcott OO, Castilla-Bancayán JP. The effect of age on the association between diabetes and mortality in adult patients with COVID-19 in Mexico. Scientific Reports. 2021;11(1):1–10.
Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney International. 2020;97(5):829–38.
Parra-Bracamonte GM, Lopez-Villalobos N, Parra-Bracamonte FE. Clinical characteristics and risk factors for mortality of patients with COVID-19 in a large data set from Mexico. Annals of Epidemiology. 2020;52:93-98.e2.
Onder G, Rezza G, Brusaferro S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA - J Am Med Assoc [Internet]. 2020;323(18):1775–6. Available from: https://jamanetwork.com/journals/jama/fullarticle/2763667
Published
How to Cite
Issue
Section
Authors who publish with Poltekita : Jurnal Ilmu Kesehatan agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
This work is licensed under a Creative Commons Attribution-ShareAlike 2.0 Generic License.
Poltekita : Jurnal Ilmu Kesehatan is licensed under a Creative Commons Attribution-Share Alike 4.0 International License
You are free to:
- Share, copy and redistribute the material in any medium or format
- Adapt, remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
